학술논문

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.
Document Type
Article
Source
International Journal of MS Care; May/Jun2016, Vol. 18 Issue 3, p138-146, 9p
Subject
THERAPEUTIC use of interferons
PEPTIDES
IMMUNOSUPPRESSIVE agents
CONTROLLED release preparations
DRUG tolerance
MULTIPLE sclerosis
PATIENT safety
DISEASE relapse
DISEASE remission
THERAPEUTICS
Language
ISSN
15372073
Abstract
Copyright of International Journal of MS Care is the property of Consortium of Multiple Sclerosis Centers and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)